The surge in swine deaths in the country continued today with five more people succumbing to the deadly virus, raising the death toll to 208 even as the government said Tamilflu drug will be available in 480 select chemist outlets.
Two deaths each were reported from Maharashtra and Gujarat while one person died in Karnataka.
On the other hand, 212 fresh cases were reported -- Delhi the maximum of 72, followed by Maharashtra (47), Tamil Nadu (38), Haryana (25) and Uttar Pradesh (7).
With these cases, the total number of people afflicted with the virus has reached 6,800.
Meanwhile, the Centre today brought out a notification for sale of Tamiflu in select pharmacies across the country.
It said the sale of 'Oseltamivir Phosphate' and 'Zanamivir' or any other preparation of Tamiflu, shall be governed by the Schedule X of the Drugs and Cosmetics Rule, 1945, which makes it mandatory for pharmacists to keep a record of prescriptions, name of the prescribing doctor and the person to whom it was sold.
The select pharmacists can procure the drug from six companies -- Ranbaxy, Cipla, Metco, Hetero, Strides and Roche -- which have the permission to manufacture the medicine.
Every manufacturer will submit to the Drugs Controller a monthly statement on the quantity of such drugs supplied by them to distributors, stockists and dealers.
You’ve reached your limit of 10 free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app

